Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

697 ARTÍCULOS , VIENDO DEL 211 AL 225

Frontal allographic agraphia in a patient with behavioral variant frontotemporal dementia

Sakurai Y, Hamada M, Takuma H.

Neurocase. 2024 Feb;30(1):32-38. doi: 10.1080/13554794.2024.2353936. Epub 2024 May 16.

Pharmacokinetic evaluation of donanemab for the treatment of Alzheimer's

Song T, Wang Y, Silverglate BD, Grossberg GT.

Expert Opin Drug Metab Toxicol. 2024 Jun;20(6):411-417. doi: 10.1080/17425255.2024.2357637. Epub 2024 May 20.

A Multidimensional, Person-Centered Framework for Functional Assessment in Dementia: Insights from the 'What', 'How', 'To Whom', and 'How Much' Questions

Slachevsky A, Grandi F, Thumala D, Baez S, Santamaria-García H, Schmitter-Edgecombe M, Parra MA.

J Alzheimers Dis. 2024;99(4):1187-1205. doi: 10.3233/JAD-230376.

Function of the hand as a predictor of early diagnosis and progression of Alzheimer's dementia: A systematic review

Namkoong S, Roh H.

Technol Health Care. 2024;32(S1):253-264. doi: 10.3233/THC-248022.

Prevention of dementia using mobile phone applications (PRODEMOS): a multinational, randomised, controlled effectiveness-implementation trial

Moll van Charante EP, Hoevenaar-Blom MP, Song M, Andrieu S, Barnes L, Birck C, Brooks R, Coley N, Eggink E, Georges J, Hafdi M, van Gool WA, Handels R, Hou H, Lyu J, Niu Y, Song L, Wang W, Wang Y, Wimo A, Yu Y, Zhang J, Zhang W, Brayne C, Wang W, Richard E; PRODEMOS study group.

Lancet Healthy Longev. 2024 Jun;5(6):e431-e442. doi: 10.1016/S2666-7568(24)00068-0. Epub 2024 May 16.

Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials

Marinheiro G, Dantas JM, Mutarelli A, Menegaz de Almeida A, Monteiro GA, Zerlotto DS, Telles JPM.

Neurol Sci. 2024 Oct;45(10):4679-4686. doi: 10.1007/s10072-024-07576-8. Epub 2024 May 20.

Immunotherapy in Alzheimer's disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline

Azargoonjahromi A.

J Pharm Pharmacol. 2024 Sep 3;76(9):1115-1131. doi: 10.1093/jpp/rgae066.

A Combined Index Using the Mini-Mental State Examination and Lawton Index to Discriminate Between Clinical Dementia Rating Scores of 0.5 and 1: A Development and Validation Study

Uchida K, Sugimoto T, Murotani K, Tsujimoto M, Kishino Y, Kuroda Y, Matsumoto N, Fujita K, Suzuki K, Ono R, Akisue T, Arai H, Toba K, Sakurai T.

J Clin Psychiatry. 2024 May 20;85(2):23m15101. doi: 10.4088/JCP.23m15101.

Adult-onset hearing loss and incident cognitive impairment and dementia - A systematic review and meta-analysis of cohort studies

Yu RC, Proctor D, Soni J, Pikett L, Livingston G, Lewis G, Schilder A, Bamiou D, Mandavia R, Omar R, Pavlou M, Lin F, Goman AM, Gonzalez SC.

Ageing Res Rev. 2024 Jul;98:102346. doi: 10.1016/j.arr.2024.102346. Epub 2024 May 23.

Sarcopenia as a Risk Factor for Alzheimer's Disease: Genetic and Epigenetic Perspectives

Raleigh SM, Orchard KJA.

Genes (Basel). 2024 Apr 27;15(5):561. doi: 10.3390/genes15050561.

Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease

Li J, Haj Ebrahimi A, Ali AB.

Int J Mol Sci. 2024 May 9;25(10):5169. doi: 10.3390/ijms25105169.

Adherence to the Mediterranean Diet, Sodium and Potassium Intake in People at a High Risk of Dementia

Rodrigues J, Costa M, Sousa D, Costa AR, Lunet N, Cruz VT, Padrão P.

Nutrients. 2024 May 8;16(10):1419. doi: 10.3390/nu16101419.

Considerations for the use of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) in cross-country comparisons of cognitive aging and dementia

Nichols E, Gross AL, Zhang YS, Meijer E, Hayat S, Steptoe A, Langa KM, Lee J.

Alzheimers Dement. 2024 Jul;20(7):4635-4648. doi: 10.1002/alz.13895. Epub 2024 May 28.

MEM&SO protocol: understanding the determinants of social learning in neurodegenerative diseases

Saliou P, Chavant J, Belliard S, Merck C, de La Sayette V, Wallon D, Martinaud O, Eustache F, Laisney M.

BMC Psychol. 2024 May 28;12(1):307. doi: 10.1186/s40359-024-01791-w.

Non-pharmacological interventions for improving language and communication in people with primary progressive aphasia

Roheger M, Riemann S, Brauer A, McGowan E, Grittner U, Flöel A, Meinzer M.

Cochrane Database Syst Rev. 2024 May 29;5(5):CD015067. doi: 10.1002/14651858.CD015067.pub2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias